company background image
ELOS

Elos Medtech OM:ELOS B Stock Report

Last Price

kr255.00

Market Cap

kr2.1b

7D

-2.3%

1Y

18.6%

Updated

24 Jun, 2022

Data

Company Financials
ELOS B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

ELOS B Stock Overview

Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets.

Rewards

Price-To-Earnings ratio (26.2x) is below the Medical Equipment industry average (35.8x)

Earnings grew by 55.2% over the past year

Risk Analysis

No risks detected for ELOS B from our risk checks.

Elos Medtech Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Elos Medtech
Historical stock prices
Current Share Pricekr255.00
52 Week Highkr477.00
52 Week Lowkr203.00
Beta1.1
1 Month Change4.51%
3 Month Change-10.84%
1 Year Change18.61%
3 Year Change157.06%
5 Year Change193.10%
Change since IPO1,600.00%

Recent News & Updates

Shareholder Returns

ELOS BSE Medical EquipmentSE Market
7D-2.3%5.6%-1.3%
1Y18.6%-35.0%-23.6%

Return vs Industry: ELOS B exceeded the Swedish Medical Equipment industry which returned -35% over the past year.

Return vs Market: ELOS B exceeded the Swedish Market which returned -23.6% over the past year.

Price Volatility

Is ELOS B's price volatile compared to industry and market?
ELOS B volatility
ELOS B Average Weekly Movement8.4%
Medical Equipment Industry Average Movement8.4%
Market Average Movement7.4%
10% most volatile stocks in SE Market12.2%
10% least volatile stocks in SE Market4.7%

Stable Share Price: ELOS B is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: ELOS B's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1923590Jodie Gilmorehttps://elosmedtech.com

Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets. It offers implants, screws, plates, orthopedic and dental instruments, drills, pins and wires, dental prosthetics, disposable plastic products, and HPLC fittings, as well as other medical plastic parts. The company also provides design and development, regulatory, prototyping, testing, OEM, process validation, and supply and inventory management, as well as design for manufacturing and engineering services.

Elos Medtech Fundamentals Summary

How do Elos Medtech's earnings and revenue compare to its market cap?
ELOS B fundamental statistics
Market Capkr2.06b
Earnings (TTM)kr78.59m
Revenue (TTM)kr746.88m

26.2x

P/E Ratio

2.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ELOS B income statement (TTM)
Revenuekr746.88m
Cost of Revenuekr476.99m
Gross Profitkr269.89m
Other Expenseskr191.30m
Earningskr78.59m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Aug 18, 2022

Earnings per share (EPS)9.74
Gross Margin36.14%
Net Profit Margin10.52%
Debt/Equity Ratio44.8%

How did ELOS B perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is ELOS B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ELOS B?

Other financial metrics that can be useful for relative valuation.

ELOS B key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3x
Enterprise Value/EBITDA15.2x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does ELOS B's PE Ratio compare to its peers?

ELOS B PE Ratio vs Peers
The above table shows the PE ratio for ELOS B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average873.5x

Price-To-Earnings vs Peers: ELOS B is good value based on its Price-To-Earnings Ratio (26.2x) compared to the peer average (873.5x).


Price to Earnings Ratio vs Industry

How does ELOS B's PE Ratio compare vs other companies in the Medical Equipment Industry?

Price-To-Earnings vs Industry: ELOS B is good value based on its Price-To-Earnings Ratio (26.2x) compared to the Swedish Medical Equipment industry average (35.8x)


Price to Earnings Ratio vs Fair Ratio

What is ELOS B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ELOS B PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio26.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ELOS B's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of ELOS B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ELOS B's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ELOS B's fair value for valuation analysis.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ELOS B's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is Elos Medtech forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


19.6%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Elos Medtech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Check out Elos Medtech's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
  • Elos Medtech competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has Elos Medtech performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


27.3%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ELOS B has high quality earnings.

Growing Profit Margin: ELOS B's current net profit margins (10.5%) are higher than last year (8.5%).


Past Earnings Growth Analysis

Earnings Trend: ELOS B's earnings have grown significantly by 27.3% per year over the past 5 years.

Accelerating Growth: ELOS B's earnings growth over the past year (55.2%) exceeds its 5-year average (27.3% per year).

Earnings vs Industry: ELOS B earnings growth over the past year (55.2%) exceeded the Medical Equipment industry 6.3%.


Return on Equity

High ROE: ELOS B's Return on Equity (11.7%) is considered low.


Discover strong past performing companies

Financial Health

How is Elos Medtech's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: ELOS B's short term assets (SEK415.6M) exceed its short term liabilities (SEK180.7M).

Long Term Liabilities: ELOS B's short term assets (SEK415.6M) exceed its long term liabilities (SEK332.4M).


Debt to Equity History and Analysis

Debt Level: ELOS B's net debt to equity ratio (31.9%) is considered satisfactory.

Reducing Debt: ELOS B's debt to equity ratio has reduced from 84.8% to 44.8% over the past 5 years.

Debt Coverage: ELOS B's debt is well covered by operating cash flow (29.6%).

Interest Coverage: ELOS B's interest payments on its debt are well covered by EBIT (15.6x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Elos Medtech current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate ELOS B's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ELOS B's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ELOS B's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ELOS B's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: ELOS B is not paying a notable dividend for the Swedish market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ELOS B has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

0.6yrs

Average management tenure


CEO

Jodie Gilmore (50 yo)

0.083

Tenure

Ms. Jodie Gilmore serves as President & Business Unit Director Orthopedic at Elos Medtech AB (publ) and had been Executive Vice President of Orthopedics from 2021 until 2022. She serves as Interim Chief Ex...


Leadership Team

Experienced Management: ELOS B's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.


Board Members

Experienced Board: ELOS B's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Elos Medtech AB (publ)'s employee growth, exchange listings and data sources


Key Information

  • Name: Elos Medtech AB (publ)
  • Ticker: ELOS B
  • Exchange: OM
  • Founded: 1923
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: kr2.057b
  • Shares outstanding: 8.07m
  • Website: https://elosmedtech.com

Number of Employees


Location

  • Elos Medtech AB (publ)
  • Torsgatan 5B
  • Gothenburg
  • Västra Götaland County
  • 411 04
  • Sweden

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/24 00:00
End of Day Share Price2022/06/23 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.